SI
Silvergate Capital·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SI
Shoulder Innovations, Inc.
A US medical device company specializing in the research and development of shoulder replacement implants and surgical instruments
Healthcare Equipment and Supplies
07/01/2009
07/31/2025
New York Stock Exchange
56
12-31
Common stock
1535 Steele Avenue SW
Suite B
Grand Rapids
Michigan 49507
--
Shoulder Innovations, Inc., was originally formed on July 1, 2009 as Shoulder Innovations, LLC, a Delaware limited liability company. On February 10, 2017, they completed a business conversion in which Shoulder Innovations, LLC was converted to Company C under Delaware law and renamed Shoulder Innovations, Inc. They are a commercial stage medical technology company focused on transforming the shoulder surgery care market. They currently offer advanced implant systems for shoulder replacements. These systems are core elements of their ecosystem, and they are designed to improve the core components of shoulder surgery care — preoperative planning, implant design, and procedural efficiency — for the benefit of every stakeholder in the care chain.
Company Financials
EPS
SI has released its 2025 Q3 earnings. EPS was reported at -0.64, versus the expected -0.37, missing expectations. The chart below visualizes how SI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SI has released its 2025 Q3 earnings report, with revenue of 11.76M, reflecting a YoY change of 57.71%, and net profit of -8.73M, showing a YoY change of -115.27%. The Sankey diagram below clearly presents SI's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
